BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6107261)

  • 1. Inhibition of gastric acid secretion in the dog by the H2-receptor antagonists, ranitidine, cimetidine, and metiamide.
    Daly MJ; Humphray JM; Stables R
    Gut; 1980 May; 21(5):408-12. PubMed ID: 6107261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive activity of furan-containing congeners of improgan and ranitidine.
    Hough LB; Menge WM; van de Stolpe AC; Nalwalk JW; Leurs R; de Esch IJ
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5715-9. PubMed ID: 17766108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety issues relating to long-term treatment with histamine H2-receptor antagonists.
    Sabesin SM
    Aliment Pharmacol Ther; 1993; 7 Suppl 2():35-40. PubMed ID: 8103374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.
    Nash J; Lambert L; Deakin M
    Drugs; 1994 Jun; 47(6):862-71. PubMed ID: 7521828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sir David Jack: an extraordinary drug discoverer and developer.
    Page C; Humphrey P
    Br J Clin Pharmacol; 2013 May; 75(5):1213-8. PubMed ID: 22994263
    [No Abstract]   [Full Text] [Related]  

  • 6. Does ranitidine provide protection against acid gastroesophageal reflux?
    Verbessem D; Camu F; Van de Velde A
    Can J Anaesth; 1993 Jan; 40(1):4-9. PubMed ID: 8425242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of gastric pH modifiers on development of intestinal metaplasia induced by X-irradiation in rats.
    Watanabe H; Okamoto T; Fudaba Y; Ogundigie PO; Ito A
    Jpn J Cancer Res; 1993 Oct; 84(10):1037-42. PubMed ID: 8226278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of ranitidine in patients with chronic duodenal ulceration: a comparison of responders and non-responders.
    McFadyen ML; Folb PI; Miller R; Marks IN; Moshal MG
    Eur J Clin Pharmacol; 1983; 24(4):441-7. PubMed ID: 6305671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cimetidine-resistant Zollinger-Ellison syndrome: successful management with ranitidine.
    Habal FM; Soldin SJ; Greenberg GR
    Can Med Assoc J; 1983 Aug; 129(3):256-8. PubMed ID: 6305470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antisecretory potency and duration of action of the H2-receptor antagonists AH 22216, cimetidine, ranitidine and SK & F 93479 in the dog.
    Stables R; Daly MJ; Humphray JM
    Agents Actions; 1983 Apr; 13(2-3):166-9. PubMed ID: 6135321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
    Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
    Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of H2-receptor antagonists and anticholinoceptor drugs on gastric and salivary secretion induced by bethanechol in the anaesthetized dog.
    Daly MJ; Humphray JM; Stables R
    Br J Pharmacol; 1982 Jul; 76(3):361-5. PubMed ID: 6125223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ranitidine on gastric acid secretory response curves to histamine, pentagastrin or bethanechol in the dog with a Heidenhain pouch.
    Daly MJ; Humphray JM; Bunce KT; Stables R
    Agents Actions; 1981 Apr; 11(1-2):160-4. PubMed ID: 6113743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.
    Walt RP; Trotman IF; Frost R; Golding PL; Shepherd TH; Rawlings J; Hunt RH; Colin-Jones D; Milton-Thompson GJ; Misiewicz JJ
    Gut; 1981 Apr; 22(4):319-22. PubMed ID: 6113192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog.
    Daly MJ; Humphray JM; Stables R
    Br J Pharmacol; 1981 Jan; 72(1):55-60. PubMed ID: 6112035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long lasting gastrin response to apomorphine revealed by inhibitors of gastric acid secretion.
    Goiny M; Brodin K; Elwin CE; Uvnäs-Moberg K
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):20-4. PubMed ID: 3627288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the H-2 receptor antagonist ranitidine on cadaver kidney allograft function.
    Orłowski T; Smogorzewski M
    Int Urol Nephrol; 1986; 18(2):205-10. PubMed ID: 3522474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of ranitidine on the pharmacokinetics and toxicity of doxorubicin in rabbits.
    Harris NL; Brenner DE; Anthony LB; Collins JC; Halter S; Hande KR
    Cancer Chemother Pharmacol; 1988; 21(4):323-8. PubMed ID: 3370741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.
    Grant SM; Langtry HD; Brogden RN
    Drugs; 1989 Jun; 37(6):801-70. PubMed ID: 2667937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethyl sulfoxide inhibits histamine release induced by various chemicals.
    Candussio L; Klugmann FB; Decorti G; Bevilacqua S; Baldini L
    Agents Actions; 1987 Feb; 20(1-2):17-21. PubMed ID: 2437774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.